Research
Excludes commercial-in-confidence projects.
Defining genomic mechanisms associated with treatment response, drug resistance and early blast crisis in chronic myeloid leukaemia, NHMRC - Research Fellowship, 01/01/2017 - 31/12/2021
Defining genomic mechanisms associated with tyrosine kinase inhibitor response, drug resistance, prognosis and progression in chronic myeloid leukaemia, Central Adelaide Local Health Network Incorporated, 21/02/2018 - 20/02/2021
An open label, randomized study of nilotinib vs. standard imatinib (400/600 mg qd) comparing the kinetics of complete molecular response for CML-CP patients with evidence of persistent leukemia by RQ, Novartis Pharmaceuticals Australia Pty Ltd, 27/03/2014 - 31/03/2016
Prediction of treatment response in CML by increased genomic instability, NHMRC - Project Grant, 01/01/2014 - 31/12/2015
Research
Research outputs for the last seven years are shown below. To see earlier years visit ORCID
Open access indicates that an output is open access.
Year | Output |
---|---|
2021 |
Open access
|
2015 |
|
Year | Output |
---|---|
2022 |
Open access
|
2022 |
Open access
|
2022 |
Open access
|
2022 |
Open access
|
2022 |
Open access
|
2022 |
Open access
|
2022 |
Open access
|
2022 |
|
2022 |
Open access
|
2022 |
Open access
1
1
1
|
2022 |
|
2021 |
Open access
15
14
6
|
2021 |
|
2021 |
Open access
11
11
20
|
2021 |
Open access
25
22
7
|
2020 |
Open access
5
4
5
|
2020 |
Open access
5
3
|
2020 |
Open access
24
23
3
|
2020 |
Open access
7
6
5
|
2020 |
Open access
11
10
1
|
2019 |
Open access
56
49
2
|
2019 |
Open access
13
10
|
2019 |
Open access
14
15
3
|
2019 |
Open access
7
6
3
|
2019 |
Open access
8
6
1
|
2019 |
Open access
16
15
7
|
2019 |
Open access
1
1
6
|
2019 |
Open access
5
5
1
|
2019 |
22
21
3
|
2018 |
Open access
87
87
8
|
2018 |
Open access
26
2
|
2018 |
Open access
7
7
3
|
2018 |
Open access
22
15
5
|
2018 |
42
35
5
|
2017 |
Open access
5
4
3
|
2017 |
Open access
621
580
924
|
2017 |
Open access
31
32
2
|
2017 |
Open access
30
26
7
|
2017 |
Open access
9
8
7
|
2017 |
Open access
264
253
64
|
2016 |
Open access
19
16
7
|
2016 |
4
5
|
2016 |
Open access
41
35
10
|
2016 |
Open access
69
68
13
|
2016 |
8
9
3
|
2016 |
Open access
18
|
2016 |
Open access
48
46
5
|
2016 |
Open access
5
5
|
2016 |
Open access
12
13
1
|
2016 |
Open access
3
2
|
2015 |
Open access
|
2015 |
Open access
68
59
2
|
2015 |
Open access
19
7
11
|
2014 |
Open access
22
20
1
|
2012 |
Open access
57
52
4
|
Year | Output |
---|---|
2019 |
Open access
1
2
|
2016 |
Open access
22
21
16
|
External engagement & recognition
Organisation | Country |
---|---|
ARIAD Pharmaceuticals | UNITED STATES |
Austin Hospital | AUSTRALIA |
Australian National University | AUSTRALIA |
Blood Institute | AUSTRALIA |
Brabois Hospital | FRANCE |
Calvary Mater Hospital | AUSTRALIA |
Catholic University of Korea | KOREA, REPUBLIC OF (SOUTH) |
Chang Gung University | TAIWAN |
Duke-NUS Medical School | SINGAPORE |
Ecole Polytechnique Federale de Lausanne | ITALY |
Federal University of Parana | BRAZIL |
Federal University of Parana (Universidade Federal do Parana) | BRAZIL |
Federal University of Rio de Janeiro | BRAZIL |
Finnish Red Cross | FINLAND |
Fiona Stanley Hospital | AUSTRALIA |
Flinders University | AUSTRALIA |
Fred Hutchinson Cancer Research Center | UNITED STATES |
Garvan Institute of Medical Research | AUSTRALIA |
Greenslopes Private Hospital | AUSTRALIA |
Hammersmith Hospital | UNITED KINGDOM |
Helsinki University Hospital | FINLAND |
Hopital Saint-Louis | FRANCE |
Howard Hughes Medical Institute | UNITED STATES |
Icon Cancer Care | AUSTRALIA |
Imperial College of Science, Technology and Medicine | UNITED KINGDOM |
John Hunter Hospital | AUSTRALIA |
Johns Hopkins University | UNITED STATES |
Kinki University | JAPAN |
Kyoto University | JAPAN |
Linkou Chang Gung Memorial Hospital | TAIWAN |
Liverpool Hospital Elizabeth | AUSTRALIA |
Mater Medical Centre | AUSTRALIA |
Mater Pathology | AUSTRALIA |
Mayo Clinic | UNITED STATES |
McMaster University | CANADA |
Memorial Sloan-Kettering Cancer Center | UNITED STATES |
Mito Medical Centre | JAPAN |
Monash University | AUSTRALIA |
Nagoya Medical Centre | JAPAN |
Nambour General Hospital | AUSTRALIA |
National Cancer Centre Singapore | SINGAPORE |
Nepean Hospital | AUSTRALIA |
New Jersey City University | UNITED STATES |
Newcastle University, United Kingdom | UNITED KINGDOM |
NHS Foundation Trust | UNITED KINGDOM |
Novartis (Australia) | AUSTRALIA |
Novartis (United Kingdom) | UNITED KINGDOM |
Novartis Healthcare | UNITED STATES |
Novartis Institutes for Biomedical Research | UNITED STATES |
Novartis Pharma AG Switzerland | SWITZERLAND |
Novartis Pharmaceuticals | UNITED STATES |
Oregon Health and Science University | UNITED STATES |
Osaka City University | JAPAN |
Osaka University | JAPAN |
Otsuka Pharmaceutical | JAPAN |
Peter MacCallum Cancer Centre | AUSTRALIA |
Princess Margaret Hospital for Children | AUSTRALIA |
Queen Elizabeth Hospital | AUSTRALIA |
Queensland Institute of Medical Research | AUSTRALIA |
Royal Adelaide Hospital | AUSTRALIA |
Royal Brisbane and Women's Hospital | AUSTRALIA |
Royal North Shore Hospital | AUSTRALIA |
SA Pathology | AUSTRALIA |
Singapore General Hospital | SINGAPORE |
Sir Charles Gardiner Hospital | AUSTRALIA |
South Australian Health and Medical Research Institute (SAHMRI) | AUSTRALIA |
St Vincents Hospital | UNITED STATES |
Statistical Revelations | AUSTRALIA |
Texas Tech University Health Sciences Center | UNITED STATES |
The Alfred Hospital | AUSTRALIA |
Toronto General Hospital | CANADA |
Universidade de Sao Paulo - USP | BRAZIL |
Universidade Fed de Minas Gerais | BRAZIL |
Universidade Federal Do Estado Do Rio De Janeiro | BRAZIL |
Universitätsklinikum Jena | GERMANY |
Universite Victor Segalen | FRANCE |
University Hospital, Bordeaux | FRANCE |
University of Adelaide | AUSTRALIA |
University of Barcelona | SPAIN |
University of Bologna | ITALY |
University of Bordeaux | FRANCE |
University of California San Francisco | UNITED STATES |
University of Chicago | UNITED STATES |
University of Helsinki | FINLAND |
University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center | FINLAND |
University of Jena | GERMANY |
University of Massachusetts Medical School | UNITED STATES |
University of Milano Bicocca | ITALY |
University of New South Wales | AUSTRALIA |
University of Newcastle | AUSTRALIA |
University Of Paris Sud (Paris 11) | FRANCE |
University of Poitiers | FRANCE |
University of Queensland | AUSTRALIA |
University of Sao Paulo | BRAZIL |
University of South Australia | AUSTRALIA |
University of Southampton | UNITED KINGDOM |
University of Sydney | AUSTRALIA |
University of Texas | UNITED STATES |
University of Texas MD Anderson Cancer Centre | UNITED STATES |
University of Toronto | CANADA |
University of Turku | FINLAND |
University of Utah | UNITED STATES |
University of Washington | UNITED STATES |
VU University Medical Center | NETHERLANDS |
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
Enhanced bioinformatics and machine learning for improved risk stratification and outcome prediction in chronic myeloid leukaemia | Current |
Interactive visualization tools for cancer genomics | Current |
Precision medicine in chronic myeloid leukaemia | Current |